Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4529 Long-term quality of life after pancreatic surgery for neuroendocrine tumours of the pancreas: Outcome of 100 patients evaluated with new EORTC questionnaires

Introduction: Patients with Pancreatic Neuroendocrine Tumours (PanNETs) often have a good prognosis with long overall survival.

Conference:

Presenting Author: Milanetto A

Authors: Milanetto A, Armellin C, Veronese E, Lorenzoni G, Pasquali C,

Keywords: net, pancreatic, quality of life,

#3690 Development of a novel NET-nutrition screening tool to identify patients requiring nutrition-related intervention and support

Introduction: Patients with neuroendocrine tumors (NET) are at risk of malnutrition, nutrient malabsorption and dietary change. Existing validated malnutrition risk screening tools are not designed to capture complex NET-related nutrition issues.

Conference:

Presenting Author: Laing E

Authors: Laing E, Kiss N, Loeliger J, Steer B, Michael M,

Keywords: neuroendocrine, nutrition, screening, diet,

#1651 Renal Neuroendocrine Tumors (rNETs): A Single-Center Experience.

Introduction: rNETs are rare tumors and little is known about their natural history.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Halfdanarson T

Authors: Westin G, Ingimarsson J, Scales J, Hobday T, Halfdanarson T,

Keywords: Renal, Kidney, NET, Carcinoid,

#1193 Health-Related Quality of Life (HRQoL) with Lanreotide Autogel (LAN) 120 mg in Patients with Enteropancreatic (EP-) NETs: Post Hoc Analyses from the CLARINET Study

Introduction: In CLARINET, favourable efficacy and safety with LAN in metastatic EP-NETs was associated with stable HRQoL outcomes.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Caplin M, Pavel M, Cwikla J, Phan A, Raderer M,

Keywords: lanreotide, quality of life,

#358 Enhanced Combined 177Lu-DOTATATE and 90Y-DOTATATE Treatment of Patients with Metastatic Neuroendocrine Tumors Refractory to Conventional Therapy: An Ongoing Study.

Introduction: Neuroendocrine tumors (NETs) over-express somatostatin receptors (SRs) and the efficacy of peptide receptor radionuclide therapy (PRRT) with somatostatin analogues labeled with high activities of ß-emitting radioisotopes have been reported.

Conference:

Presenting Author:

Authors: Mallia A, Seregni E, Maccauro M, Chiesa C, Coliva A,

Keywords: Neuroendocrine tumors,peptide receptor radionuclide therapy. Study is partially supported by a grant from the Min.of Health (5 per mille) and Italian Association of Cancer (AIRC).,